Cargando…

Effect of angiotensin converting enzyme inhibitor on glomerular hyperfiltration in patients with type 1 diabetes

OBJECTIVE: To assess the effect of angiotensin converting enzyme inhibition on glomerular filtration rate (GFR) in normotensive patient with type 1 diabetes. METHODS: A two year non-placebo control prospective study was conducted after ethical approval at Diabetes Centre of Diabetic Association of P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naqvi, S. A. Jaffar, Ahsan, Shahid, Fawwad, Asher, Basit, Abdul, Shera, A Samad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928398/ https://www.ncbi.nlm.nih.gov/pubmed/27375689 http://dx.doi.org/10.12669/pjms.323.9399

Ejemplares similares

Frequency, severity and risk indicators of retinopathy in patients with diabetes screened by fundus photographs: a study from primary health care
por: Memon, Saleh, et al.
Publicado: (2014)

Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016–2017
por: Basit, Abdul, et al.
Publicado: (2018)

Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney
por: Tuttle, Katherine R.
Publicado: (2017)

Phlorizin Prevents Glomerular Hyperfiltration but not Hypertrophy in Diabetic Rats
por: Malatiali, Slava, et al.
Publicado: (2008)

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
por: Ruggenenti, Piero, et al.
Publicado: (2012)

Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease
por: Yang, Yang, et al.
Publicado: (2022)

Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing
por: Zoccali, Carmine, et al.
Publicado: (2023)

Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease
por: WANG, WEISONG, et al.
Publicado: (2013)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Renal Dysfunction in Prediabetes: Confirmed by Glomerular Hyperfiltration and Albuminuria
por: Shilpasree, Alagilawada S., et al.
Publicado: (2021)

Diabetes Registry of Pakistan
por: Basit, Abdul, et al.
Publicado: (2020)

Hemodynamic and biological correlates of glomerular hyperfiltration in sickle cell patients before and under renin–angiotensin system blocker
por: Haymann, Jean-Philippe, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Sub-morbid dehydration-associated glomerular hyperfiltration: An emerging reality?
por: Min, Hyang Ki, et al.
Publicado: (2019)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Injury to the Endothelial Surface Layer Induces Glomerular Hyperfiltration Rats with Early-Stage Diabetes
por: Zhang, Chunyang, et al.
Publicado: (2014)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin converting enzyme-2 as therapeutic target in COVID-19
por: Roshanravan, Neda, et al.
Publicado: (2020)

Sex Differences in Glomerular Lesions, in Atherosclerosis Progression, and in the Response to Angiotensin-Converting Enzyme Inhibitors in the ApoE(−/−) Mice Model
por: Mallén, Adrián, et al.
Publicado: (2023)

Glomerular hyperfiltration is associated with dementia: A nationwide population-based study
por: Kang, Min Woo, et al.
Publicado: (2020)

Association of Glomerular Hyperfiltration and Cardiovascular Risk in Middle-Aged Healthy Individuals
por: Dupuis, Marie-Eve, et al.
Publicado: (2020)

Pakistan’s Recommendations for Optimal Management of diabetes from Primary to Tertiary care level (PROMPT)
por: Shera, A. Samad, et al.
Publicado: (2017)

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
por: Ajmal, Adnan, et al.
Publicado: (2013)

Insulin Prevents Hyperfiltration and Proteinuria but Not Glomerular Hypertrophy and Increases Mesangial Matrix Expansion in Diabetic Rats
por: Malatiali, Slava, et al.
Publicado: (2017)

Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients
por: Aggarwal, Neerja, et al.
Publicado: (2017)

Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors
por: Caballero, Julio
Publicado: (2020)

Structure and Function of Angiotensin Converting Enzyme and Its Inhibitors
por: Zhao, Yulan, et al.
Publicado: (2008)

Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors
por: Yu, Zhiyin, et al.
Publicado: (2023)

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2020)

Frequency of depression among patients with Type-I diabetes in a developing country, Pakistan
por: Riaz, Musarrat, et al.
Publicado: (2017)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy
por: Pathak, Jahnavi V., et al.
Publicado: (2015)

NDSP 09: Risk Assessment of Pakistani Individual for Diabetes (RAPID) – Findings from Second National Diabetes Survey of Pakistan (NDSP) 2016–2017
por: Abdul Basit, Khalid, et al.
Publicado: (2021)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
por: Kriszta, Gábor, et al.
Publicado: (2021)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
por: Mamdani, Muhammad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vhba7k4r7eg9m7jj6v3p4s8ltf